Browsing by Subject "Alzheimer disease"
Now showing items 1-2 of 2
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
(Brac University, 2023-10)Alzheimer’s disease is a neurodegenerative disease. Using FDA Adverse Event Reporting System database, a pharmacovigilance study for gender specific rhabdomyolysis risk in memantine users was conducted between January ... -
Immunotherapy for Alzheimer’s disease
(Brac University, 2022-02)Alzheimer's disease is one kind of a brain disorder which has the capability to destroy a person’s memory and thinking ability. To treat this disease various types of immunotherapies are required. This review is basically ...
